FDA ap­proves the first gener­ic for life-sav­ing opi­oid over­dose treat­ment nalox­one that can be car­ried by un­trained in­di­vid­u­als

On av­er­age, opi­oids kill more than 130 Amer­i­cans every day. An ef­fec­tive agent to halt or re­verse the ef­fects of an opi­oid over­dose is nalox­one, which is avail­able as a nasal spray, an in­jec­tion, or as an in­tra­venous in­fu­sion, and works by tem­porar­i­ly pre­vent­ing the opi­oids from at­tach­ing to opi­oid re­cep­tors in the brain. On Fri­day, the FDA ap­proved the first gener­ic ver­sion of nalox­one nasal spray that can be used to re­verse sus­pect­ed over­dose in the com­mu­ni­ty set­ting, made by Is­rael’s Te­va $TE­VA.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.